Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin

PURPOSE: The aim of this study is to analyze the outcomes of platinum-sensitive (PS) recurrent ovarian cancer treated with pegylated liposomal doxorubicin and carboplatin (CD) versus paclitaxel and carboplatin (CP). Clinical features were examined to characterize the patient population that would be...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Weng, Chia-Sui, Wu, Chao-Chih, Chen, Tze-Chien, Chen, Jen-Ruei, Huang, Chueh-Yi, Chang, Chih-Long
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6877447/
https://ncbi.nlm.nih.gov/pubmed/31819627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217329
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires